Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review

TNF-α inhibitors (TNFis) have revolutionized the treatment of certain chronic immune-mediated diseases, being widely and successfully used in rheumatic inflammatory diseases, and have also proved their efficacy in the treatment of inflammatory bowel disease (IBD). However, among the side effects of...

Full description

Bibliographic Details
Main Authors: Ioana Ruxandra Mihai, Alexandra Maria Burlui, Ioana Irina Rezus, Cătălina Mihai, Luana Andreea Macovei, Anca Cardoneanu, Otilia Gavrilescu, Mihaela Dranga, Elena Rezus
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/8/1779
_version_ 1827729381184765952
author Ioana Ruxandra Mihai
Alexandra Maria Burlui
Ioana Irina Rezus
Cătălina Mihai
Luana Andreea Macovei
Anca Cardoneanu
Otilia Gavrilescu
Mihaela Dranga
Elena Rezus
author_facet Ioana Ruxandra Mihai
Alexandra Maria Burlui
Ioana Irina Rezus
Cătălina Mihai
Luana Andreea Macovei
Anca Cardoneanu
Otilia Gavrilescu
Mihaela Dranga
Elena Rezus
author_sort Ioana Ruxandra Mihai
collection DOAJ
description TNF-α inhibitors (TNFis) have revolutionized the treatment of certain chronic immune-mediated diseases, being widely and successfully used in rheumatic inflammatory diseases, and have also proved their efficacy in the treatment of inflammatory bowel disease (IBD). However, among the side effects of these agents are the so-called paradoxical effects. They can be defined as the appearance or exacerbation of a pathological condition that usually responds to this class of drug while treating a patient for another condition. A wide range of paradoxical effects have been reported including dermatological, intestinal and ophthalmic conditions. The causal mechanism of occurrence may implicate an imbalance of cytokines, but is still not fully understood, and remains a matter of debate. These paradoxical reactions often show improvement on discontinuation of the medication or on switching to another TNFi, but in some cases it is a class effect that could lead to the withdrawal of all anti-TNF agents. Close monitoring of patients treated with TNFis is necessary in order to detect paradoxical reactions. In this study we focus on reviewing IBD occurrence as a paradoxical effect of TNFi therapy in patients with rheumatological diseases (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis).
first_indexed 2024-03-10T23:48:02Z
format Article
id doaj.art-f7375dbf04ed45faa568d2e22ad9dd78
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T23:48:02Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-f7375dbf04ed45faa568d2e22ad9dd782023-11-19T01:55:35ZengMDPI AGLife2075-17292023-08-01138177910.3390/life13081779Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A ReviewIoana Ruxandra Mihai0Alexandra Maria Burlui1Ioana Irina Rezus2Cătălina Mihai3Luana Andreea Macovei4Anca Cardoneanu5Otilia Gavrilescu6Mihaela Dranga7Elena Rezus8Department of Rheumatology and Rehabilitation, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Rheumatology and Rehabilitation, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Dermatovenerology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Gastroenterology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Rheumatology and Rehabilitation, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Rheumatology and Rehabilitation, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Gastroenterology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Gastroenterology, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaDepartment of Rheumatology and Rehabilitation, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaTNF-α inhibitors (TNFis) have revolutionized the treatment of certain chronic immune-mediated diseases, being widely and successfully used in rheumatic inflammatory diseases, and have also proved their efficacy in the treatment of inflammatory bowel disease (IBD). However, among the side effects of these agents are the so-called paradoxical effects. They can be defined as the appearance or exacerbation of a pathological condition that usually responds to this class of drug while treating a patient for another condition. A wide range of paradoxical effects have been reported including dermatological, intestinal and ophthalmic conditions. The causal mechanism of occurrence may implicate an imbalance of cytokines, but is still not fully understood, and remains a matter of debate. These paradoxical reactions often show improvement on discontinuation of the medication or on switching to another TNFi, but in some cases it is a class effect that could lead to the withdrawal of all anti-TNF agents. Close monitoring of patients treated with TNFis is necessary in order to detect paradoxical reactions. In this study we focus on reviewing IBD occurrence as a paradoxical effect of TNFi therapy in patients with rheumatological diseases (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis).https://www.mdpi.com/2075-1729/13/8/1779paradoxical reactionanti-TNF-αinflammatory bowel diseaseCrohn’s diseaseulcerative colitisbiologic therapy
spellingShingle Ioana Ruxandra Mihai
Alexandra Maria Burlui
Ioana Irina Rezus
Cătălina Mihai
Luana Andreea Macovei
Anca Cardoneanu
Otilia Gavrilescu
Mihaela Dranga
Elena Rezus
Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
Life
paradoxical reaction
anti-TNF-α
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
biologic therapy
title Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
title_full Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
title_fullStr Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
title_full_unstemmed Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
title_short Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
title_sort inflammatory bowel disease as a paradoxical reaction to anti tnf α treatment a review
topic paradoxical reaction
anti-TNF-α
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
biologic therapy
url https://www.mdpi.com/2075-1729/13/8/1779
work_keys_str_mv AT ioanaruxandramihai inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT alexandramariaburlui inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT ioanairinarezus inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT catalinamihai inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT luanaandreeamacovei inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT ancacardoneanu inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT otiliagavrilescu inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT mihaeladranga inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview
AT elenarezus inflammatoryboweldiseaseasaparadoxicalreactiontoantitnfatreatmentareview